BOHLIN GAREN G 4
4 · Karyopharm Therapeutics Inc. · Filed May 21, 2021
Insider Transaction Report
Form 4
BOHLIN GAREN G
Director
Transactions
- Award
Nonstatutory Stock Option (right to buy)
2021-05-21+23,900→ 23,900 totalExercise: $9.42Exp: 2031-05-20→ Common Stock (23,900 underlying)
Footnotes (1)
- [F1]This option vests as to 100% of the underlying shares on the earlier of May 21, 2022 or the next annual meeting of stockholders of Karyopharm Therapeutics Inc. (the "Issuer"), provided that the reporting person continues to serve as a director of the Issuer through such date.